Shurong Chang
- Molecular Biology top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Oncology top 10%
- Genetics top 10%
- Cancer Research top 10%
- Co-authors
- Eric N. OlsonTimothy A. McKinseyChun Li ZhangJoseph A. HillJames A. RichardsonChristopher L. AntosXiaoxia QiShijie Li
- Topics
- Signaling Pathways in Disease (4 papers)Histone Deacetylase Inhibitors Research (4 papers)Peptidase Inhibition and Analysis (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Shurong Chang
8 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Molecular Biology 1.9k
- Cardiology and Cardiovascular Medicine 462
- Oncology 419
- Genetics 246
- Cancer Research 185
Countries citing papers authored by Shurong Chang
This map shows the geographic impact of Shurong Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shurong Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shurong Chang more than expected).
Fields of papers citing papers by Shurong Chang
This network shows the impact of papers produced by Shurong Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shurong Chang. The network helps show where Shurong Chang may publish in the future.
Co-authorship network of co-authors of Shurong Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Shurong Chang. A scholar is included among the top collaborators of Shurong Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shurong Chang. Shurong Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 109 | |
| 2 | 166 | |
| 3 | 362 | |
| 4 | 141 | |
| 5 | 90 | |
| 6 | 490 | |
| 7 | Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophybreakdown → | 793 |
| 8 | 9 |
About Shurong Chang
Shurong Chang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology, having authored 8 papers that have together received 2.2k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Cardiology and Cardiovascular Medicine (462 citations) and Oncology (419 citations). Shurong Chang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Eric N. Olson, Timothy A. McKinsey, Chun Li Zhang, Joseph A. Hill, James A. Richardson, Christopher L. Antos, Xiaoxia Qi, Shijie Li, Bryan D. Young and Shijie Li. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.